로딩 중...
52주 최고가 대비 57.5% 위치
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $3.92B | $3.96B | $3.79B | $3.68B |
| 영업이익 | - | $364.0M | $289.0M | $188.0M | $252.0M |
| 당기순이익 | - | $-950.0M | $-132.0M | $-910.0M | $-598.0M |
| 잉여현금흐름 (FCF) | - | $368.0M | $228.0M | $281.0M | $104.0M |
| 수익성 비율 | |||||
| 영업이익률 | - | 9.3% | 7.3% | 5.0% | 6.8% |
| 순이익률 | - | -24.2% | -3.3% | -24.0% | -16.3% |
| ROE (자기자본이익률) | - | -24.9% | -4.0% | -46.9% | -44.7% |
| ROA (자산이익률) | - | -12.4% | -1.8% | -15.8% | -11.0% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | 1.1% | -4.3% | -3.0% |
| EPS 성장률 (YoY) | - | - | 85.9% | -622.6% | 33.0% |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | - | - | - | - | - |
| PBR (주가순자산배수) | - | 1.8x | 2.0x | 1.9x | 1.9x |
| PSR (주가매출배수) | - | 1.7x | 1.6x | 1.0x | 0.7x |
| FCF Yield | - | 5.5% | 3.5% | 7.4% | 4.2% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | 0.56 | 0.70 | 1.17 | 1.84 |
| 유동비율 | - | 1.62 | 1.38 | 1.10 | 1.51 |
MOLINA HEALTHCARE INC
$179.86
$9.4B